(S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (JJ novel) (NN cancer) (JJ diagnostic) (NN method)) (PP (VBN based) (PP (IN on) (NP (NP (NML (NN plasma) (NN denaturation)) (NNS profiles)) (VP (VBN obtained) (PP (IN by) (NP (NP (DT a) (JJ non-conventional) (NN use)) (PP (IN of) (NP (NNP Differential) (NN Scanning) (NN Fluorimetry))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (CD 84) (NN glioma) (NNS patients)) (CC and) (NP (CD 63) (JJ healthy) (NNS controls))) (VP (MD can) (VP (VB be) (ADVP (RB automatically)) (VP (VBN classified) (S (VP (VBG using) (NP (NN denaturation) (NNS profiles)) (PP (IN with) (NP (NP (DT the) (NN help)) (PP (IN of) (NP (NML (NN machine) (NN learning)) (NNS algorithms))))) (PP (IN with) (NP (NP (CD 92) (NN %)) (NP (NN accuracy)))))))))))) (. .))
(S (NP (VBN Proposed) (NML (JJ high) (NN throughput)) (NN workflow)) (VP (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (IN to) (NP (NP (DT any) (NN type)) (PP (IN of) (NP (NN cancer)))))))) (CC and) (VP (MD could) (VP (VB become) (NP (DT a) (JJ powerful) (NN pan-cancer) (ADJP (JJ diagnostic) (CC and) (VBG monitoring)) (NN tool)) (PP (IN from) (NP (DT a) (JJ simple) (NN blood) (NN test)))))) (. .))
